Business Wire

CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Sodium Chloride Injection, USP, 0.9% Due to Product Labeling Incorrectly Stating Stoppers Do Not ...

Fresenius Kabi USA is voluntarily recalling 164 lots of Sodium Chloride Injection, USP, 0.9%, 10 mL fill in a 10 mL vial and Sodium Chloride Injection, USP, 0.9%, 20 mL fill in a 20 mL vial to the ...
Monthly Prescribing Reference

Recall: Particulates Found in Sodium Chloride 0.9% Injection

Hospira had notified the public last August that it initiated a voluntary nationwide user-level recall of one lot of 0.9% Sodium Chloride Injection, USP, 100mL, Flexible Container, NDC 0409-7984-23.
FiercePharma

Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter

FOR IMMEDIATE RELEASE — January 20, 2015 — LAKE FOREST, Ill., — Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, ...
FiercePharma

Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market

Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market DEERFIELD, Ill., May 15, 2015 - Baxter International Inc. (NYSE: BAX) ...
Business Wire

Nexus Pharmaceuticals Receives FDA Approval for 0.9% Sodium Chloride Injection

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals LLC announced it has received U.S. Food and Drug Administration (FDA) approval for 0.9% Sodium Chloride Injection, USP in 10mL and 20mL ...